Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 19Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Osteosarcoma 2Water Intoxication 1Psoriasis 1Ototoxicity 1Neoplasm, Residual 1Myasthenia Gravis 1Leukemia 1Inflammatory Bowel Diseases 1Hematologic Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Dementia 1Central Nervous System Neoplasms 1Breast Neoplasms 1Breast Cancer Organoids 1Alzheimer Disease 1Acute Kidney Injury 1

Interventions

Psychiatric Rehabilitation 4Immunohistochemistry 4Gene Expression Profiling 4Amplified Fragment Length Polymorphism Analysis 4Radiotherapy 3gadobenic acid 2Surveys and Questionnaires 2Polymerase Chain Reaction 2Microarray Analysis 2Mental Status and Dementia Tests 2Magnetic Resonance Imaging 2In Situ Hybridization, Fluorescence 2Gene Rearrangement 2Cytogenetic Analysis 2Comparative Genomic Hybridization 2gadoteridol 1Vincristine 1Tissue Banks 1Temozolomide 1Specimen Handling 1Respiratory Function Tests 1Radiosurgery 1Quality of Life 1Pulse Wave Analysis 1Positron-Emission Tomography 1Phlebotomy 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Methotrexate 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Central Nervous System Neoplasms × Methotrexate × Clear all
NCT00683319 2013-09-20

Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy

National Cancer Institute (NCI)

Active not recruiting
50 enrolled
CNS

Ototoxicity, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡